Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Magdalena K. Zielińska
Observed names:
M.K. Zielińska,
Magdalena Zielinska,
Zielińska, Magdalena
Institutions:
Medical University of Warsaw,
Dana-Farber Cancer Institute,
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Medical University of Warsaw,
Dana-Farber Cancer Institute,
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0009-0009-5366-2538
Observed ORCID:
0009-0009-5366-2538
OpenAlex ID:
A5104186147
Eradicating Drug-tolerant Persister Cells in EGFR- Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
·
Cancer Discovery
·
44
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It
2025
·
Magdalena K. Zielińska
, Magdalena Ciążyńska
, et al.
·
Biomolecules
·
36
PDF
1115P Comparison of efficacy and toxicity of dabrafenib/trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice
2023
·
K. Piejko
, B. Cybulska-Stopa
, et al.
·
Annals of Oncology
·
2
PDF
1176P Planned drug holidays during immunotherapy in advanced and metastatic melanoma patients: A nation-wide study
2023
·
A.M. Czarnecka
, P. Teterycz
, et al.
·
Annals of Oncology
·
1
PDF
Data from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Figure S2 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S11 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S5 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S4 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S1 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S3 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S10 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Figure S6 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S7 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S8 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S9 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Table S1 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Table S2 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Cardiac tumor as first presentation of melanoma
2025
·
Magdalena K. Zielińska
, Monika Dudzisz-Śledź
, et al.
·
Oncology in Clinical Practice
PDF
Show more works
View as search
Works count:
20
Citation count:
83
H-index:
2
I10-index:
2
Year
Topic
Type